Bipartisan Bill Seeks to Compel FDA to Regulate CBD as Dietary Supplement

January 17, 2020 16:00:13

The new decade brings good tidings for the budding hemp/CBD sector. A bipartisan coalition of lawmakers has introduced a bill that would allow sellers to market hemp-derived CBD as a dietary supplement. The 2018 Farm Bill legalized industrial hemp, classifying cannabis with less than 0.3% THC as legal hemp. Thus hemp and its extracts, including CBD, could be marketed and sold legally.

The THC limit, however, was the extent of regulation the sector received. Apart from that, sellers had no rules to go by, and by the time the FDA was taking notice, the sector was booming, with experts estimating…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.